Keros Therapeutics
Patents, Design & Utilities

Last updated:

List of all Keros Therapeutics patents 11 in total

Status Patent
Application
Utility: ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: ALK2 ANTIBODIES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 19 Aug 2021
Grant
Utility: Activin receptor type IIa variants and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 17 Aug 2021
Application
Utility: CRYSTAL FORMS OF AN ALK2 INHIBITOR External link
Filling date: 6 Sep 2025 Issue date: 5 Aug 2021
Grant
Utility: Activin receptor type IIA variants and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 25 May 2021
Application
Utility: ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 25 Feb 2021
Application
Utility: ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: ACTIVIN RECEPTOR TYPE IIB VARIANTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 31 Dec 2020
Application
Utility: ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 14 Nov 2019
Application
Utility: GDNF FUSION POLYPEPTIDES AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 19 Sep 2019

Showing 1 to 11 of 11 patents.